Ex-CV Sales Rep Drops Ranexa Marketing Suit

Law360, New York (December 17, 2010, 7:02 PM EST) -- A former CV Therapeutics Inc. sales representative has dropped his False Claims Act suit accusing the company of endangering heart patients through off-label marketing of its angina drug Ranexa following the federal government's refusal to intervene in the case.

Plaintiff Ricardo Forges cited only the government’s decision not to intervene in his one-paragraph notice of voluntary dismissal filed Thursday in the U.S. District Court for the Northern District of California.

According to Forges’ October 2008 complaint against CV, the U.S. Food and Drug Administration only approved...
To view the full article, register now.